Overview of B-Cell Lymphoma-Related NCCN Guideline Development
Leo Gordon, MD, provides an overview of current treatment strategies currently driven by NCCN guidelines.
Examining Frontline PV Treatment Options
Dr Gerds navigates frontline treatments for patients diagnosed with PV.
Considerations Related to Development of PV-Related NCCN Treatment Guidelines
Dr Gerds reviews the process for updating NCCN guidelines surrounding PV treatment.
Decisions and Challenges in Multidisciplinary Teams
Experts examine decision-makers in treatment selection and navigate challenges in organizing multidisciplinary team meetings, from institutional to wider practice perspectives.
Navigating Use of Immunotherapy in mNSCLC
Specialists discuss adverse reactions to immunotherapy and explore the importance of CTLA-4 inhibitors in mNSCLC treatment.
Overcoming Diversity Challenges and Exploring Immune Checkpoint Inhibitor Strategies in mNSCLC Treatment
Professionals deliberate the progression of Immuno-Oncology combinations while also engaging in conversations regarding the issue of immunotherapy resistance.
Optimal Multidisciplinary (MDT) Approach for the Management of NSCLC
A panel of experts review what an effective multidisciplinary approach for NSCLC management looks like and subspecialties included in multidisciplinary teams.
Evolving Standard of CKD Care for Patients with Significant Comorbidities
The current treatment landscape for CKD patients with preexisting comorbidities is explored.
Goals of Therapy for Patients Diagnosed with CKD
Dr Nicholas highlights key objectives in developing CKD treatment strategies.
Medication Access Programs for Patients
An overview of the importance of specialty pharmacies, coupons, and product samples.
Advocating for Patients to Payer for More Beneficial Therapies
A discussion on advocating for patients to payers over high-cost drugs and generic drugs.
NCCN-Directed Guidelines Driving PV Treatment in Clinical Practice
Dr. Gerd examines the clinical choices involved in the management of PV, following the directives of NCCN guidelines.
Differentiations Between Symptomatic Versus Asymptomatic Patients with PV
Dr Gerds explores similarities and differences in symptomatic patients compared to asymptomatic patients with PV.
Advancements in NSCLC Profiling and Understanding Immunotherapy Resistance
Experts examine primary and acquired resistance mechanisms in immunotherapy, while promoting realistic treatment strategies.
Challenges and Benefits of Next-Generation Sequence Testing in mNSCLC
Experts explore the utilization of next-generation sequencing, including liquid biopsies, in mNSCLC Diagnosis.
Implications and Considerations Related to Reimbursement of mAbs
In their closing thoughts the panelists discuss reimbursement-related considerations surrounding mAbs.
Early Intervention Impacting CKD Treatment Pathways
Clinical and financial considerations surrounding screening and early intervention for CKD are discussed by key opinion leaders.
Identifying Patients Eligible for the CKD Screening Process
The screening process for CKD is discussed by Susanne Nicholas, MD, MPH, PhD.
Barriers to Care Which Limit Patient Access to Medication
A conversation on barriers which prevent patients from obtaining medications; including cost, co-pays, and prior authorization.
Triple Combination: Clindamycin, Benzoyl Peroxide, and Adapalene
An overview of the combination therapy of clindamycin, benzoyl peroxide, and adapalene.
Innovations Needed in GI Cancer and Key Takeaways from ESMO 2023
John L. Marshall M.D., explains the importance of in-person conferences and the future of AI in the field.
Risk Factors and Complications Associated with Polycythemia Vera (PV)
Risk factors for developing polycythemia vera (PV) are discussed by Aaron Gerds, MD, MS.
Treating Patients with Non-Driver Mutations mNSCLC
Experts share insights on the use chemotherapy and immunotherapy in driver-negative patients, along with the use of PD-L1 inhibitors.
The Influence of Precision Medicine on the Treatment of Patients with Driver Mutations in mNSCLC
Experts discuss the significance of treatment selection in patients with driver mutations.
Financial Impact Associated With RSV
RSV diagnosis can lead to an array of financial complications.
Current Status of Chronic Kidney Disease in the US
A panel of medical experts begin a discussion addressing the incidence and prevalence of chronic kidney disease (CKD).
Navigating CKD Treatment Among Comorbidities
Dr Haumschild drives a conversation regarding CKD treatment in the presence comorbidities such as cardiovascular disease and type 2 diabetes.
LEAP-017: Lenvatinib and Pembrolizumab in MSS mCRC
The LEAP-017 trial results presented at ESMO GI 2023 are explored by Dr Marshall.
Newer Agents in Treatment Algorithms
Discussion on treatment algorithms as well as the impact of sebum in acne patients.
Adverse Effects in Topical and Oral Medications
An overview on adverse effects for topical clascoterone, minocycline, and trifarotene
